Filing Details
- Accession Number:
- 0001723128-19-000038
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-03-07 17:41:33
- Reporting Period:
- 2019-03-06
- Accepted Time:
- 2019-03-07 17:41:33
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1723128 | Amneal Pharmaceuticals Inc. | AMRX | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1238456 | R Peter Terreri | C/O Amneal Pharmaceuticals, Inc. 400 Crossing Boulevard, 3Rd Floor Bridgewater NJ 08807 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Common Stock | Disposition | 2019-03-06 | 23,345 | $12.39 | 25,192 | No | 4 | S | Direct | |
Class A Common Stock | Acquisiton | 2019-03-06 | 45,000 | $6.55 | 70,192 | No | 4 | M | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | M | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Class A Common Stock | Stock Option | Disposition | 2019-03-06 | 45,000 | $0.00 | 45,000 | $6.55 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2019-05-20 | No | 4 | M | Direct |
Footnotes
- The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.39 per share to $12.38 per share. The reporting person undertakes to provide Amneal Pharmaceuticals, Inc., any security holder of Amneal Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The option is vested and currently exercisable.